Novo CEO pressed by Senate to chop costs of weight problems, diabetes prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the business would think about new talks with insurers in regards to the list selling prices of Wegovy and copyright should they pledge to help keep the medicines on their https://arizonahardteacarbs50594.activosblog.com/29934118/considerations-to-know-about-healthcare-news